Insulet Corporation (Nasdaq: PODD) announced the first patient has completed the feasibility study of the Omnipod Horizon™ Automated Glucose Control ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE